Literature DB >> 17645587

How can we prevent cardiovascular disease in diabetes.

O Wiklund1, L Håversen, C Pettersson, L M Hultén.   

Abstract

Evidence based goals for the treatment and prevention of atherosclerosis in diabetes are given in international and national guidelines. The importance of optimal control of lipids and blood pressure has been shown in several studies. With available drugs and behavioural modifications the treatment goals can be reached in most cases. However, only a few patients with diabetes are treated optimally today. A major possibility to reduce cardiovascular disease in diabetes is to treat patients according to guidelines. New treatment targets may include specific treatment of the dyslipidaemia, manifested in high levels of small dense LDL and low HDL, active anti-inflammatory treatments, specific reduction of inflammatory activity in adipose tissue, reduced volume of adipose tissue, antioxidants and reduction of advanced glycosylation endproducts production. Possible strategies for these treatments are available, and should be evaluated in clinical trials.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645587     DOI: 10.1111/j.1365-2796.2007.01828.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  4 in total

Review 1.  Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?

Authors:  Kawser Akter; Emily A Lanza; Stephen A Martin; Natalie Myronyuk; Melanie Rua; Robert B Raffa
Journal:  Br J Clin Pharmacol       Date:  2011-03       Impact factor: 4.335

2.  Survival disparities in patients with lymphoma according to place of residence and treatment provider: a population-based study.

Authors:  Fausto R Loberiza; Anthony J Cannon; Dennis D Weisenburger; Julie M Vose; Matt J Moehr; Martin A Bast; Philip J Bierman; R Gregory Bociek; James O Armitage
Journal:  J Clin Oncol       Date:  2009-09-14       Impact factor: 44.544

3.  Flexible initial dosing of atorvastatin based upon initial low-density lipoprotein cholesterol levels in type 2 diabetic patients.

Authors: 
Journal:  Korean J Intern Med       Date:  2008-03       Impact factor: 3.165

4.  Antihyperlipemic and antihypertensive effects of Spirulina maxima in an open sample of Mexican population: a preliminary report.

Authors:  Patricia V Torres-Duran; Aldo Ferreira-Hermosillo; Marco A Juarez-Oropeza
Journal:  Lipids Health Dis       Date:  2007-11-26       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.